Michelle C. Miller - Search Results

Year	Number of Results
2009	3
2011	3
2012	4
2013	3
2014	2
2015	3
2016	2
2017	3
2018	2
2019	5
2020	4
2021	3
2022	1
2023	3
2024	1

1

Chemokines from a Structural Perspective.

Miller MC, Mayo KH. Miller MC, et al. Int J Mol Sci. 2017 Oct 2;18(10):2088. doi: 10.3390/ijms18102088. Int J Mol Sci. 2017. PMID: 28974038 Free PMC article. Review.

2

Galectins as Molecular Targets for Therapeutic Intervention.

Dings RPM, Miller MC, Griffin RJ, Mayo KH. Dings RPM, et al. Among authors: miller mc. Int J Mol Sci. 2018 Mar 19;19(3):905. doi: 10.3390/ijms19030905. Int J Mol Sci. 2018. PMID: 29562695 Free PMC article. Review.

3

Chemokines and galectins form heterodimers to modulate inflammation.

Eckardt V, Miller MC, Blanchet X, Duan R, Leberzammer J, Duchene J, Soehnlein O, Megens RT, Ludwig AK, Dregni A, Faussner A, Wichapong K, Ippel H, Dijkgraaf I, Kaltner H, Döring Y, Bidzhekov K, Hackeng TM, Weber C, Gabius HJ, von Hundelshausen P, Mayo KH. Eckardt V, et al. Among authors: miller mc. EMBO Rep. 2020 Apr 3;21(4):e47852. doi: 10.15252/embr.201947852. Epub 2020 Feb 21. EMBO Rep. 2020. PMID: 32080959 Free PMC article.

4

Topsy-turvy binding of negatively charged homogalacturonan oligosaccharides to galectin-3.

Zheng Y, Su J, Miller MC, Geng J, Xu X, Zhang T, Mayzel M, Zhou Y, Mayo KH, Tai G. Zheng Y, et al. Among authors: miller mc. Glycobiology. 2021 Apr 1;31(3):341-350. doi: 10.1093/glycob/cwaa080. Glycobiology. 2021. PMID: 32909036

5

An Oral Galectin Inhibitor in COVID-19-A Phase II Randomized Controlled Trial.

Sigamani A, Mayo KH, Miller MC, Chen-Walden H, Reddy S, Platt D. Sigamani A, et al. Among authors: miller mc. Vaccines (Basel). 2023 Mar 25;11(4):731. doi: 10.3390/vaccines11040731. Vaccines (Basel). 2023. PMID: 37112643 Free PMC article.

6

Molecular basis for cellular retinoic acid-binding protein 1 in modulating CaMKII activation.

Nhieu J, Miller MC, Lerdall TA, Mayo KH, Wei LN. Nhieu J, et al. Among authors: miller mc. Front Mol Biosci. 2023 Sep 26;10:1268843. doi: 10.3389/fmolb.2023.1268843. eCollection 2023. Front Mol Biosci. 2023. PMID: 37822422 Free PMC article.

7

Galectin-3 N-terminal tail prolines modulate cell activity and glycan-mediated oligomerization/phase separation.

Zhao Z, Xu X, Cheng H, Miller MC, He Z, Gu H, Zhang Z, Raz A, Mayo KH, Tai G, Zhou Y. Zhao Z, et al. Among authors: miller mc. Proc Natl Acad Sci U S A. 2021 May 11;118(19):e2021074118. doi: 10.1073/pnas.2021074118. Proc Natl Acad Sci U S A. 2021. PMID: 33952698 Free PMC article.

8

PLG-007 and Its Active Component Galactomannan-α Competitively Inhibit Enzymes That Hydrolyze Glucose Polymers.

Miller MC, Dregni AJ, Platt D, Mayo KH. Miller MC, et al. Int J Mol Sci. 2022 Jul 13;23(14):7739. doi: 10.3390/ijms23147739. Int J Mol Sci. 2022. PMID: 35887087 Free PMC article.

9

Structural features for α-galactomannan binding to galectin-1.

Miller MC, Klyosov AA, Mayo KH. Miller MC, et al. Glycobiology. 2012 Apr;22(4):543-51. doi: 10.1093/glycob/cwr173. Epub 2011 Dec 7. Glycobiology. 2012. PMID: 22156919 Free PMC article.

10

A new regulatory mechanism for Raf kinase activation, retinoic acid-bound Crabp1.

Park SW, Nhieu J, Persaud SD, Miller MC, Xia Y, Lin YW, Lin YL, Kagechika H, Mayo KH, Wei LN. Park SW, et al. Among authors: miller mc. Sci Rep. 2019 Jul 29;9(1):10929. doi: 10.1038/s41598-019-47354-7. Sci Rep. 2019. PMID: 31358819 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

35 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

35 results

Results by year